These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
947 related items for PubMed ID: 8525521
1. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin. Dono K, Maki T, Wood ML, Monaco AP. Transplantation; 1995 Dec 15; 60(11):1268-73. PubMed ID: 8525521 [Abstract] [Full Text] [Related]
2. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Ohzato H, Monaco AP. Transplantation; 1992 Dec 15; 54(6):1090-5. PubMed ID: 1465774 [Abstract] [Full Text] [Related]
3. Skin allograft survival following intrathymic injection of donor bone marrow. Cober SR, Randolph MA, Lee WP. J Surg Res; 1999 Aug 15; 85(2):204-8. PubMed ID: 10423320 [Abstract] [Full Text] [Related]
4. Prevention by thymectomy of tolerance induced by intrathymic injection of donor splenocytes. Nakafusa Y, Goss JA, Flye MW. Surgery; 1993 Aug 15; 114(2):183-9; discussion 189-90. PubMed ID: 8342124 [Abstract] [Full Text] [Related]
6. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA, Gottschalk R, Maki T, Monaco AP. Transplantation; 1998 Feb 27; 65(4):473-9. PubMed ID: 9500619 [Abstract] [Full Text] [Related]
7. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA, Gottschalk R, Fukuzaki T, Wood ML, Maki T, Monaco AP. Transplantation; 1997 Feb 15; 63(3):359-64. PubMed ID: 9039923 [Abstract] [Full Text] [Related]
9. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice. Rodríguez-Barbosa JI, Haller GW, Zhao G, Sachs DH, Sykes M. Transpl Immunol; 2005 Oct 15; 15(1):25-33. PubMed ID: 16223670 [Abstract] [Full Text] [Related]
10. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation. Shen Z, Mohiuddin M, DiSesa VJ. Ann Thorac Surg; 1995 Dec 15; 60(6):1683-5. PubMed ID: 8787463 [Abstract] [Full Text] [Related]
12. MHC class II presenting cells are necessary for the induction of intrathymic tolerance. Goss JA, Nakafusa Y, Flye MW. Ann Surg; 1993 May 15; 217(5):492-9; discussion 499-501. PubMed ID: 8489312 [Abstract] [Full Text] [Related]
17. Donor-specific unresponsiveness to murine cardiac allografts induced by intrathymic-soluble alloantigens is dependent on alternate pathway of antigen presentation. Chowdhury NC, Jin MX, Hardy MA, Oluwole SF. J Surg Res; 1995 Jul 15; 59(1):91-6. PubMed ID: 7630143 [Abstract] [Full Text] [Related]
18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y, Tang XD, Zhou PJ. Scand J Immunol; 2005 Mar 15; 61(3):266-73. PubMed ID: 15787744 [Abstract] [Full Text] [Related]
19. Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Oluwole SF, Jin MX, Chowdhury NC, Ohajekwe OA. Transplantation; 1994 Nov 27; 58(10):1077-81. PubMed ID: 7974714 [Abstract] [Full Text] [Related]